By inhibiting the kinase activity of PDK1, DIC initiates a cascade of alterations in multiple phenotypes of ovarian cancer SKOV3 and A2780 cells, including antagonizing the Warburg effect, increasing ROS production, and inducing apoptosis, which leads to effective inhibition of tumor growth in vivo. Here, PDK1 is linked to ovarian carcinoma.